Intel Corporation 10-Q Summary: Period Ended June 28, 1997
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 28, 1997, and the six-month period ended on the same date. Intel Corporation, a Delaware corporation, is the world's leading manufacturer of microprocessors. The financial statements are unaudited but reflect all normal recurring adjustments. Notably, a two-for-one stock split was effected on July 13, 1997, and all share and per-share data in this filing have been restated to reflect this split.
Key Financial Metrics
| Metric (in millions) | Q2 1997 | Q2 1996 | 6 Months 1997 | 6 Months 1996 |
|---|---|---|---|---|
| Net Revenues | $5,960 | $4,621 | $12,408 | $9,265 |
| Cost of Sales | $2,343 | $2,150 | $4,650 | $4,571 |
| Gross Margin % | 61% | 53% | 63% | 51% |
| Operating Income | $2,338 | $1,515 | $5,205 | $2,820 |
| Net Income | $1,645 | $1,041 | $3,628 | $1,935 |
| Earnings Per Share | $0.92 | $0.59 | $2.02 | $1.09 |
| Cash from Operations (6mo) | $4,133 (vs $3,822 prior year) | |||
| Cash & Investments | $9.5 billion (as of June 28, 1997) | |||
| Short-term Debt | $181 million | |||
| Long-term Debt | $468 million |
Material Changes vs. Prior Period
- Revenue Growth: Q2 1997 revenues increased 29% year-over-year, driven by higher volumes of Pentium processors (including MMX technology), Pentium Pro, and Pentium II processors, alongside a shift toward higher-performance product mixes. Chipset revenues also grew significantly.
- Margin Expansion: Gross margin improved to 61% in Q2 1997 from 53% in Q2 1996. This was primarily due to favorable product mix shifts and volume efficiencies, partially offset by higher start-up costs for the .25 micron manufacturing process.
- Expense Increases: Operating expenses (R&D and SG&A) rose 34% in Q2 1997 compared to the prior year, reflecting increased investment in process technology and the "Intel Inside" marketing program. However, expenses remained at 21% of revenues, consistent with the prior year.
- Interest Income: Interest and other income surged $130 million in Q2 1997 due to higher average investment balances and gains on equity investment sales.
- Share Repurchases: Intel repurchased 28.4 million shares for $2.1 billion during the first half of 1997. The Board authorized an additional 60 million shares for repurchase, bringing total authorization to 280 million shares.
Guidance, Outlook, and Risks
- Q3 1997 Outlook: Management expects Q3 revenues to be flat to slightly up from Q2's $6.0 billion. Gross margin is expected to be flat to slightly down from 61%.
- Full Year 1997 Guidance: Gross margin is projected at 60% plus or minus a few points, with expectations to be in the mid-to-high end of that range. Capital expenditures are expected to be approximately $4.5 billion, and depreciation is revised down to approximately $2.2 billion.
- Acquisition: On July 27, 1997, Intel announced a definitive agreement to acquire Chips and Technologies, Inc. for approximately $416 million via a tender offer. The transaction is subject to regulatory approval and shareholder lawsuits challenging the offer.
- Legal Proceedings: Intel is defending against patent infringement suits from Digital Equipment Corporation (DEC) and Cyrix Corporation. Additionally, a former employee (Michael W. Scriber) is seeking $1.2 billion in damages for alleged patent infringement. Management does not believe these litigations will have a material adverse effect on financial position.
- Risks: Key risks include product mix volatility, price reductions, inventory obsolescence, manufacturing yield issues, and the successful integration of acquisitions.
Investor Verification Checklist
- Product Mix Sensitivity: Verify the impact of the shift to Pentium II and MMX processors on average selling prices and gross margins, as noted in the outlook.
- Acquisition Status: Monitor the progress of the Chips and Technologies tender offer and the outcome of the shareholder lawsuits challenging the transaction.
- Legal Exposure: Track developments in the DEC, Cyrix, and Scriber patent litigation cases to assess potential future liabilities or injunctions.
- Capital Allocation: Confirm the execution of the $4.5 billion capital expenditure plan and the continued pace of share repurchases under the expanded authorization.
- Accounting Changes: Note the upcoming adoption of SFAS No. 128 (Earnings Per Share) and SFAS No. 130/131 in fiscal 1998, which will alter reporting metrics.